Similarly, SIRT2 deficiency enhances the progression of NAFLD by altering gut microbiota composition and inducing metabolic disorders [6], whereas inhibiting SIRT2 may improve gut barrier integrity and protect against colitis [111]. The gene discussed is SIRT2; the disease is metabolic disease.